Inventor · disambiguated record
Tomohiro Seki
Also filed as: SEKI TOMOHIRO
7 granted patents·4 pending applications·13 citations·filing 2016–2025
78Inventor score
Top patents by PatentIndex Score
11 records- 0190US10980825B2Cyclic dinucleotideTAKEDA PHARMACEUTICALS CO·Filed 2018·Granted Apr 20, 2021·6 cites·20 claims
- 0289US11666594B2Antibody-drug conjugates comprising a cyclic dinucleotideTAKEDA PHARMACEUTICALS CO·Filed 2020·Granted Jun 6, 2023·2 cites·19 claims
- 0388US10787462B2Heterocyclic compoundTAKEDA PHARMACEUTICALS CO·Filed 2016·Granted Sep 29, 2020·5 cites·14 claims
- 0482US2025205270A1Antibody-drug conjugate precursors comprising a cyclic dinucleotideTAKEDA PHARMACEUTICALS CO·Filed 2024·Application pending·0 cites
- 0580US12171777B2Methods of making a cyclic dinucleotideTAKEDA PHARMACEUTICALS CO·Filed 2023·Granted Dec 24, 2024·0 cites·20 claims
- 0669US2023295628A1Nucleic acid complexUNIV NAT CORP TOKYO MEDICAL & DENTAL·Filed 2023·Application pending·0 cites
- 0765US11597928B2Nucleic acid complexUNIV NAT CORP TOKYO MEDICAL & DENTAL·Filed 2019·Granted Mar 7, 2023·0 cites·20 claims
- 0860US12305169B2BBB-crossing lipid ligand of hetero nucleic acidUNIV NAT CORP TOKYO MEDICAL & DENTAL·Filed 2019·Granted May 20, 2025·0 cites·28 claims
- 0954US12065453B2Lanthanoid compound, lanthanoid-containing thin film and formation of lanthanoid-containing thin film using the lanthanoid compoundAIR LIQUIDE·Filed 2019·Granted Aug 20, 2024·0 cites·13 claims
- 1053US2022370491A1Nucleic acid complexUNIV NAT CORP TOKYO MEDICAL & DENTAL·Filed 2020·Application pending·0 cites
- 1152US2025333736A1Bbb-crossing lipid ligand of hetero nucleic acidUNIV NAT CORP TOKYO MEDICAL & DENTAL·Filed 2025·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Tomohiro Seki files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →